“victor babes” university of medicine and pharmacy timisoara
DESCRIPTION
“Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA. DEPARTMENT OF MEDICAL INFORMATICS 2005 / 2006. “Medical Scientific Research Methodology” “MCS” 2 nd Module Course 2. RISK AND PROGNOSTIC FACTORS ANALYSIS. 1.1. RISK FACTORS. a) DEFINITION : - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/1.jpg)
““Victor Babes”Victor Babes”UNIVERSITY OF UNIVERSITY OF
MEDICINE AND PHARMACY MEDICINE AND PHARMACY TIMISOARATIMISOARA
““Victor Babes”Victor Babes”UNIVERSITY OF UNIVERSITY OF
MEDICINE AND PHARMACY MEDICINE AND PHARMACY TIMISOARATIMISOARA
DEPARTMENT OFDEPARTMENT OF
MEDICAL INFORMATICS MEDICAL INFORMATICS
2005 / 20062005 / 2006
![Page 2: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/2.jpg)
““Medical Scientific Research Methodology”Medical Scientific Research Methodology”“MCS”“MCS”
22ndnd Module Module
Course 2Course 2
![Page 3: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/3.jpg)
1.1. RISK AND RISK AND
PROGNOSTIC FACTORSPROGNOSTIC FACTORS
ANALYSISANALYSIS
![Page 4: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/4.jpg)
1.1. RISK FACTORS1.1. RISK FACTORS
• a) DEFINITION : a) DEFINITION : – Hypothetical cause for disease Hypothetical cause for disease
occurrence or facilitationoccurrence or facilitation– b) CLASSIFICATION :b) CLASSIFICATION :
• Environmental factorsEnvironmental factors• SocialSocial• BehaviorialBehaviorial• BiologicalBiological
![Page 5: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/5.jpg)
1.2. METHODS1.2. METHODS
– A- EXPERIMENTAL A- EXPERIMENTAL • RISK FACTOR CONTROLRISK FACTOR CONTROL
• DISADVANTAGE: ETHICAL DISADVANTAGE: ETHICAL REASONSREASONS
– B- OBSERVATION-BASEDB- OBSERVATION-BASED
![Page 6: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/6.jpg)
• a) TRANSVERSAL (CROSS – SECTIONAL) a) TRANSVERSAL (CROSS – SECTIONAL) – Moment situation in a large sampleMoment situation in a large sample
• b) LONGITUDINAL (Evolution in time)b) LONGITUDINAL (Evolution in time)– COHORT COHORT – Two groups: Exposed / Unexposed Two groups: Exposed / Unexposed – ProspectiveProspective– [Cohort retrospective][Cohort retrospective]– CASE - CONTROLCASE - CONTROL– Two groups: Disease / No-diseaseTwo groups: Disease / No-disease– RetrospectiveRetrospective
Comparison:Comparison:– EXP > COH.pr. > COH.ret. > CASE-C. > CR.S.EXP > COH.pr. > COH.ret. > CASE-C. > CR.S.
![Page 7: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/7.jpg)
![Page 8: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/8.jpg)
1.3. CONTINGENCY TABLES1.3. CONTINGENCY TABLESa) Cross sectional, Cohort and Case-Control a) Cross sectional, Cohort and Case-Control
independent samples (unpaired)independent samples (unpaired)
D+ (disease)
D- (no disease)
Total rows
E+ (exposed) N11 N12 L1
E- (nonexposed) N21 N22 L2
Total columns
C1 C2 N
![Page 9: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/9.jpg)
b) Paired (matched) groups – b) Paired (matched) groups – cohortcohort
N11, N12, N21, N22 = pairs (expl)N11, N12, N21, N22 = pairs (expl)
E- Non-exposed D+ (disease) D- (no disease)
Total rows
D+ N11 N12 L1
E+
Exposed D- N21 N22 L2
Total columns
C1 C2 N
![Page 10: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/10.jpg)
c) Paired (matched) groups – c) Paired (matched) groups – case-controlcase-control
N11, N12, N21, N22 = pairs (expl)N11, N12, N21, N22 = pairs (expl)
D- (no disease) E+ Exposed E- Non-exposed
Total rows
E+ Exposed N11 N12 L1
D+
(disease) E- Non-exposed N21 N22 L2
Total columns
C1 C2 N
![Page 11: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/11.jpg)
1.4. FONDAMENTAL PARAMETERS IN 1.4. FONDAMENTAL PARAMETERS IN EPIDEMIOLOGYEPIDEMIOLOGY
• ABSOLUTE RISK (‘success’ rate):ABSOLUTE RISK (‘success’ rate):
R (E+) = p(D+/E+) = N11 / L1R (E+) = p(D+/E+) = N11 / L1
R (E-) = p(D+/E-) = N21 / L2R (E-) = p(D+/E-) = N21 / L2
• RELATIVE RISK (RR):RELATIVE RISK (RR):
RR = R(E+) / R(E-)RR = R(E+) / R(E-)
RR = N11 . L2 / N21 . L1RR = N11 . L2 / N21 . L1
![Page 12: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/12.jpg)
ATTRIBUTABLE RISK :ATTRIBUTABLE RISK : (EXCESS OF RISK DUE TO EXPOSURE)(EXCESS OF RISK DUE TO EXPOSURE)
AR = P(D+/E+) – P(D+/E-)AR = P(D+/E+) – P(D+/E-)
POPULATION ATTRIBUTABLE RISK :POPULATION ATTRIBUTABLE RISK : (EXCESS OF RISK IN POPULATION)(EXCESS OF RISK IN POPULATION)
PAR = AR PAR = AR xx P(E+) P(E+)
ATTRIBUTABLE FRACTION:ATTRIBUTABLE FRACTION: (AR %, ETIOLOGICAL FRACTION)(AR %, ETIOLOGICAL FRACTION)
AFAFE E = AR/P(D+/E+) = (RR-1)/RR= AR/P(D+/E+) = (RR-1)/RR
POPULATION ATTRIBUTABLE FRACTION:POPULATION ATTRIBUTABLE FRACTION: (PAR %, TOTAL ETIOLOGICAL FRACTION)(PAR %, TOTAL ETIOLOGICAL FRACTION)
AFAFTT = PAR/P(D+) = PAR/P(D+)
![Page 13: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/13.jpg)
• ‘‘ODD’ INDEX (‘success / failure’):ODD’ INDEX (‘success / failure’):
- for cohort:- for cohort: ODD (D+/E+) = P(D+/E+)/P(D-/E+) = N11 / N12ODD (D+/E+) = P(D+/E+)/P(D-/E+) = N11 / N12 ODD (D+/E-) = P(D+/E-)/P(D-/E-) = N21 / N22ODD (D+/E-) = P(D+/E-)/P(D-/E-) = N21 / N22
- for case-control:- for case-control: ODD (E+/D+) = P(E+/D+)/P(E-/D+) = N11 / N21ODD (E+/D+) = P(E+/D+)/P(E-/D+) = N11 / N21 ODD (E+/D-) = P(E+/D-)/P(E-/D-) = N21 / N22ODD (E+/D-) = P(E+/D-)/P(E-/D-) = N21 / N22
![Page 14: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/14.jpg)
• ODDS RATIO (OR) – independent groupsODDS RATIO (OR) – independent groups– for cohortfor cohort
OR = ODD(D+/E+) / ODD(D+/E-)OR = ODD(D+/E+) / ODD(D+/E-)– for case-controlfor case-control
OR = ODD(E+/D+) / ODD(E+/D-)OR = ODD(E+/D+) / ODD(E+/D-)
OR = N11 . N22 / N21 . N12 OR = N11 . N22 / N21 . N12
![Page 15: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/15.jpg)
• ODDS RATIO (OR) – matched groupsODDS RATIO (OR) – matched groups– for cohortfor cohort
OR = ODD(D+/E+) / ODD(D+/E-)OR = ODD(D+/E+) / ODD(D+/E-)– for case-controlfor case-control
OR = ODD(E+/D+) / ODD(E+/D-)OR = ODD(E+/D+) / ODD(E+/D-)
OR = N12 / N21 OR = N12 / N21
• Usually OR > RRUsually OR > RR• If OR > 1 (RR > 1) ==> RISK !If OR > 1 (RR > 1) ==> RISK !
![Page 16: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/16.jpg)
Confidence IntervalsConfidence Intervals
• Limits for OR: UP = upper limit, LL = lower…Limits for OR: UP = upper limit, LL = lower…– for 95%:for 95%:
ln (UL & LL) = ln (OR) ± 1.96 x
• Accept RISK if the whole interval (LL,UL) >1Accept RISK if the whole interval (LL,UL) >1
22
1
21
1
12
1
11
1
NNNN
![Page 17: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/17.jpg)
![Page 18: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/18.jpg)
2. Biostatistics chapters2. Biostatistics chapters• Introduction: variables, samplesIntroduction: variables, samples• Statistical parameters (of a sample)Statistical parameters (of a sample)• Statistical estimation (for a population)Statistical estimation (for a population)• Statistical tests (comparison – differences)Statistical tests (comparison – differences)• Correlation and regression (association)Correlation and regression (association)• Epidemiological studies (risk, association)Epidemiological studies (risk, association)• Special applicationsSpecial applications
Survival analysis (time series)Survival analysis (time series)
Sequencial analysis (bioinformatics)Sequencial analysis (bioinformatics)
Health statisticsHealth statistics
![Page 19: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/19.jpg)
2.1. STATISTICAL INFERENCE2.1. STATISTICAL INFERENCE
• A. GENERAL CONCEPTSA. GENERAL CONCEPTS– a) population, individuala) population, individual– b) definition: Biostatistics = b) definition: Biostatistics = science of science of
estimating population characteristics and estimating population characteristics and comparing populationscomparing populations
– c) methods:c) methods:• census - all individuals; the same timecensus - all individuals; the same time• screening - large number; selection criteriascreening - large number; selection criteria• sampling - subset of populationsampling - subset of population
![Page 20: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/20.jpg)
– d) STATISTICAL INFERENCE d) STATISTICAL INFERENCE • EXTENDING PROPERTIES COMPUTED FOR EXTENDING PROPERTIES COMPUTED FOR
A SAMPLE TO A POPULATIONA SAMPLE TO A POPULATION
– e) REPRESENTATIVE SAMPLE e) REPRESENTATIVE SAMPLE • CRITERIA:CRITERIA:
– EQUIPROPBABILITYEQUIPROPBABILITY– INDEPENDENCEINDEPENDENCE
– f) SELECTION METHODSf) SELECTION METHODS• SIMPLE SELECTIONSIMPLE SELECTION
– RANDOM NUMBERS ASSOCIATEDRANDOM NUMBERS ASSOCIATED
• MULTIPLE LAYER SELECTIONMULTIPLE LAYER SELECTION• MIXED SELECTION MIXED SELECTION
– CLUSTERSCLUSTERS
![Page 21: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/21.jpg)
• B. VARIABLESB. VARIABLES– a) DEFINITION:a) DEFINITION:
• a population characteristic which is studied and a population characteristic which is studied and measured on all sampled individualsmeasured on all sampled individuals
– b) STARTING A STUDYb) STARTING A STUDY• variable selectionvariable selection• measurement accuracymeasurement accuracy• sample sizesample size
– c) TYPES OF VARIABLES:c) TYPES OF VARIABLES:• NUMERICALNUMERICAL• ORDINAL (rank)ORDINAL (rank)• NOMINAL (qualitative, count data)NOMINAL (qualitative, count data)
![Page 22: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/22.jpg)
• C. STUDY DESIGNC. STUDY DESIGN
– Setting scope (hypothesis, objectives, study plan)Setting scope (hypothesis, objectives, study plan)• variable selectionvariable selection• measurement accuracymeasurement accuracy• sample sizesample size• choosing the processing method and accepted limitschoosing the processing method and accepted limits
– Representative sampleRepresentative sample– Data collectionData collection– Preliminary data presentaionPreliminary data presentaion
• tablestables• graphs (graphs (histograms,“pie”, lines, scatter, maps)histograms,“pie”, lines, scatter, maps)
– DATA PROCESSING - CONCLUSIONSDATA PROCESSING - CONCLUSIONS– Writing the protocol and the paper (+ error estimation)Writing the protocol and the paper (+ error estimation)
![Page 23: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/23.jpg)
![Page 24: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/24.jpg)
![Page 25: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/25.jpg)
![Page 26: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/26.jpg)
![Page 27: “Victor Babes” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA](https://reader036.vdocument.in/reader036/viewer/2022081507/568159c7550346895dc719bf/html5/thumbnails/27.jpg)
~ Pause ~~ Pause ~